Anti-PD-1/PD-L1 Antibody Therapy for Pretreated Advanced or Metastatic Nonsmall Cell Lung Carcinomas and the Correlation between PD-L1 Expression and Treatment Effectiveness: An Update Meta-Analysis of Randomized Clinical Trials

PURPOSE: This meta-analysis systematically evaluated the efficacy and safety of anti-PD-1/PD-L1 antibodies for pretreated advanced or metastatic nonsmall cell lung cancer (NSCLC) and investigated the correlation between PD-L1 expression levels and effectiveness of anti-PD-1/PD-L1 antibody. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qiuling, Xie, Ruixiang, Lin, Shen, You, Xiang, Weng, Xiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174790/
https://www.ncbi.nlm.nih.gov/pubmed/30345301
http://dx.doi.org/10.1155/2018/3820956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174790/
https://www.ncbi.nlm.nih.gov/pubmed/30345301
http://dx.doi.org/10.1155/2018/3820956

Ejemplares similares